EU agency sees no new risks with combined contraceptives
LONDON (Reuters) - European drug regulators said on Friday there was no reason for women to stop using
combined contraceptives like Bayer's Meliane (gestodene plus ethinyl estradiol) or Yasmin (drospirenone plus
ethinyl estradiol) since there was no new evidence pointing to safety risks.
Source: Modern Medicine - Category: Journals (General) Source Type: news